Patients | Gender | Age (year) | Locationa | Gradeb | Total times of receiving denosumab | Follow-up, (months) | MSTS 93 score | Complications | Recurrence or metastasis |
---|---|---|---|---|---|---|---|---|---|
1 | Female | 37 | I | III | 4 | 45 | 25 | NA | NA |
2 | Female | 58 | I | III | 5 | 38 | 27 | NA | NA |
3 | Male | 23 | I | III | 4 | 35 | 26 | NA | NA |
4 | Female | 59 | I + II | III | 8 | 32 | 23 | NA | NA |
5 | Female | 43 | II + III | III | 6 | 39 | 23 | Delayed wound healing | NA |
6 | Male | 29 | I + II + III | III | 10 | 30 | 24 | NA | NA |
7 | Female | 50 | II + III | III | 5 | 28 | 23 | NA | NA |